Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Clinical trial NCT06470464 · COMPLETED
Trial details
- NCT number
- NCT06470464
- Sponsor
- Shandong First Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-11
- Primary completion
- 2024-06-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.